NIIHARA YUTAKA (Chairman and CEO) purchased 0.4% of their position (52.60K shares) of EMMAUS LIFE SCIENCES, INC. on the open market
Open‑market purchase worth $21.2K — a small addition. The strongest form of insider conviction signal.
Common stock, $0.001 par value
Shares
+2.50K
Price / share
$0.45
Trade value
$1.13K
% of position
Common stock, $0.001 par value
Shares
+7.50K
Price / share
$0.45
Trade value
$3.38K
% of position
Common stock, $0.001 par value
Shares
+5K
Price / share
$0.35
Trade value
$1.75K
% of position
Common stock, $0.001 par value
Shares
+14.70K
Price / share
$0.38
Trade value
$5.59K
% of position
Common stock, $0.001 par value
Shares
+22.90K
Price / share
$0.41
Trade value
$9.39K
% of position
Net shares
+52.60K
Net value
$21.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.001 par value Direct | 11/3/2022 | P · Purchase | +2.50K | $0.45 | $1.13K | 0.0% | 11.99M | 11.99M |
| Common stock, $0.001 par value Direct | 11/4/2022 | P · Purchase | +7.50K | $0.45 | $3.38K | 0.1% | 11.99M | 12M |
| Common stock, $0.001 par value Direct | 11/28/2022 | P · Purchase | +5K | $0.35 | $1.75K | 0.0% | 12M | 12M |
| Common stock, $0.001 par value Direct | 11/29/2022 | P · Purchase | +14.70K | $0.38 | $5.59K | 0.1% | 12M | 12.02M |
| Common stock, $0.001 par value Direct | 11/30/2022 | P · Purchase | +22.90K | $0.41 | $9.39K | 0.2% | 12.02M | 12.04M |
| Total | +52.60K | $21.23K | ||||||
Common stock, $0.001 par value
IndirectCommon stock, $0.001 par value
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock, $0.001 par value | 92.79K | Indirect |
| Common stock, $0.001 par value | 63K | Indirect |
| Total | 155.79K | 155.79K indirect |